Slingshot members are tracking this event:

FibroGen (FGEN) set to release data on pamrevlumab and fibrosis (IPF) Phase 2 trial in 2017

Do you think this event is important to the companies below? How will it affect their stock price?

Related Companies
High Medium Low
Impact on Stocks
FGEN Community voting in process
Slingshot Insights Explained
Catalyst Date
Occurred on:
Aug 07, 2017
Occurred Source:
Related Projects Image
  • Don’t see a project related to the catalyst you care about?

Related Keywords Pamrevlumab And Fibrosis, Ipf